https://www.zacks.com/stock/news/2193273/general-mills-gis-rises-as-market-takes-a-dip-key-facts?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v2-2193273
Dec 04, 2023 - The latest trading day saw General Mills (GIS) settling at $64.95, representing a +1.28% change from its previous close.
zc:-534205041560864599
0
https://www.zacks.com/stock/news/2193264/franklin-covey-fc-rises-as-market-takes-a-dip-key-facts?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v1-2193264
Dec 04, 2023 - In the latest trading session, Franklin Covey (FC) closed at $39.54, marking a +0.61% move from the previous day.
zc:3409210622565491415
0
https://www.zacks.com/stock/news/2193248/united-airlines-ual-rises-as-market-takes-a-dip-key-facts?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6-2193248
Dec 04, 2023 - United Airlines (UAL) reachead $40.52 at the closing of the latest trading day, reflecting a +0.7% change compared to its last close.
zc:3215793784637536005
0
https://www.zacks.com/stock/news/2193155/unlocking-q1-potential-of-vail-resorts-mtn-exploring-wall-street-estimates-for-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2193155
Dec 04, 2023 - Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Vail Resorts (MTN), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended October 2023.
zc:6728977400163543267
0
https://www.zacks.com/stock/news/2193059/countdown-to-ciena-cien-q4-earnings-wall-street-forecasts-for-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2193059
Dec 04, 2023 - Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Ciena (CIEN), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended October 2023.
zc:7310435726252275889
0
https://www.zacks.com/stock/news/2193056/wall-street-s-insights-into-key-metrics-ahead-of-lululemon-lulu-q3-earnings?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2193056
Dec 04, 2023 - Beyond analysts' top -and-bottom-line estimates for Lululemon (LULU), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended October 2023.
zc:-1495337196420112479
0
https://www.zacks.com/stock/news/2192994/northrim-bancorp-nrim-s-technical-outlook-is-bright-after-key-golden-cross?cid=CS-ZC-FT-tale_of_the_tape|golden_crossover-2192994
Dec 04, 2023 - When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
zc:4978239398507510291
0
https://www.zacks.com/stock/news/2192928/compared-to-estimates-carvana-cvna-q3-earnings-a-look-at-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm-2192928
Dec 04, 2023 - The headline numbers for Carvana (CVNA) give insight into how the company performed in the quarter ended September 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
zc:6109976501932256670
0
https://www.zacks.com/stock/news/2192929/compared-to-estimates-okta-okta-q3-earnings-a-look-at-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm-2192929
Dec 04, 2023 - The headline numbers for Okta (OKTA) give insight into how the company performed in the quarter ended October 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
zc:9066123773779204562
0
https://seekingalpha.com/article/4655595-abbvie-4-hidden-keys-investors-must-know-to-judge-immunogen-acquisition?source=feed_all_articles
Dec 03, 2023 - AbbVie has agreed to acquire ImmunoGen for $10 billion, nearly double its previous trading price. Read more about ABBV stock here.
0
sa:3579563865101086986
0